Epigenetic modification of miR-429 can manipulate LCSCs by targeting the RBBP4/E2F1/Oct4 axis, suggesting that targeting miR-429 might inactivate LCSCs, thus providing a novel strategy for HCC prevention and treatment (Li et al., 2015). Here, POU5F1 is linked to hepatocellular carcinoma.